73T-13015-47724
1 vaccination
1 coded response
5 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 05-11
- ZIP prefix
- 950 / CA
- Registered
- 2021-11-20
- Relationship
- Child or adolescent in my care
- Guardian
- 666-29324-97237
- Race
- N/A
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-08
Dose 1 — Pfizer-BioNTech
-
2021-11-20
Registered in v-safe
- 2021-11-20
- 2021-11-22
-
2022-02-07
Survey response — 3 months, dose 1, dependentMedDRA: Headache, Oropharyngeal pain, Pyrexia, SARS-CoV-2 test negative, Viral upper respiratory tract infection — Feeling: Good · Be unable to work or attend schoolFree text: She contracted an upper respiratory virus, but tested negative for COVID. Had low grade fever, sore throat, and headache. The symptoms resolved in about 4 daysMedDRA releases: 2024-11 · check-in free text available
- 2022-05-09
- 2022-11-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-11-08 | Pfizer-BioNTech | No |
Free text
Release 11 — 3 months, dose 1, dependent
Symptoms: She contracted an upper respiratory virus, but tested negative for COVID. Had low grade fever, sore throat, and headache. The symptoms resolved in about 4 days
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Viral upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release